HOME >> BIOLOGY >> NEWS
Stanford researchers create diabetic fruit flies in lab

STANFORD, Calif. - Researchers at Stanford University Medical Center have created fruit flies with a condition that mimics human diabetes. Although it's a big evolutionary leap from flies to humans, the researchers say their tiny diabetic "patients" will help scientists understand how insulin-releasing cells develop - a first step toward replacing cells lost in human diabetes.

"The idea is that the more you know about normal development the better chance you have to make stem cells develop into insulin-producing cells," said Eric Rulifson, PhD, a postdoctoral fellow in developmental biology and lead author of a paper due out in the May 10 issue of Science.

Insulin's normal role in the body is to help muscle, liver and fat cells take up sugar from the blood and use it for energy. In Type I diabetes (also known as juvenile diabetes), the immune system destroys pancreatic cells that produce insulin. Without insulin, sugar accumulates in the blood, damaging the eyes, kidneys, blood vessels and nerves, and preventing the body from converting sugar to energy. People with Type I diabetes must inject insulin in order to survive.

One potential cure involves using stem cells to generate replacements for the lost insulin-producing cells. The problem is coaxing those stem cells to develop into pancreatic cells rather than some unrelated cell type. To entice those cells down the correct developmental pathway, researchers need to know how the cells normally develop.

This is where the fruit fly excels, said Roel Nusse, PhD, professor of developmental biology and co-author on the paper. Although flies are less complicated than humans, they retain the same basic biological process and are much easier to study. "There are many examples of functions that are conserved between flies and humans," said Nusse, who is also an investigator at the Howard Hughes Medical Institute.

As an example, Nusse points out that one branch of the immune system is
'"/>

Contact: Amy Adams
amyadams@stanford.edu
650-723-3900
Stanford University Medical Center
9-May-2002


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide ... clients to strengthen their laboratory supply chain for more than 10 years. Early ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage in ... COVID cure or vaccine, the global economic downturn will only increase price pressures overall ... away and capturing full value from every product launch is critical. However, history shows ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler ... (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering ... 50 million stem cells total, patients may choose which extremities they would like treated. ... joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted ... will cover the history of eSource, the reasons it did not take off as ... to site source, the industry is moving towards capturing data electronically for clinical trials ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
Breaking Biology Technology:
Cached News: